Literature DB >> 14703950

Dose individualization in PharmDIS-e+.

J H Proost1, N C Punt.   

Abstract

Individualized dosage regimen calculations require knowledge on the pharmacokinetic and pharmacodynamic properties of the drug and the characteristics of the patient. A PK-PD-based dosage regimen is not easily and generally applicable, mainly because the combination of available PK parameters and therapeutic target levels may be inappropriate for the purpose of predicting a plausible dosage regimen. Within the project PharmDIS-e+, an alternative approach was chosen, and this "PK and standard dose"-based principle is well suited for computerized dosing advice. PharmDIS-e+ aims at the development of several applications for dosing regimen advice for general practitioners, hospital physicians and pharmacists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14703950     DOI: 10.5414/cpp41451

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  1 in total

1.  [Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function].

Authors:  Sebastian Maus; Caecilia Holch; David Czock; Florian Thalhammer; Frieder Keller; Bertram Hartmann
Journal:  Wien Klin Wochenschr       Date:  2010-08-04       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.